JPS62142150A - 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 - Google Patents
中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法Info
- Publication number
- JPS62142150A JPS62142150A JP28488086A JP28488086A JPS62142150A JP S62142150 A JPS62142150 A JP S62142150A JP 28488086 A JP28488086 A JP 28488086A JP 28488086 A JP28488086 A JP 28488086A JP S62142150 A JPS62142150 A JP S62142150A
- Authority
- JP
- Japan
- Prior art keywords
- arginine
- crystals
- neutral
- malic acid
- neutral salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 title claims description 44
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 title claims description 41
- 230000007935 neutral effect Effects 0.000 title claims description 34
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 title claims description 28
- 229930064664 L-arginine Natural products 0.000 title claims description 28
- 235000014852 L-arginine Nutrition 0.000 title claims description 28
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 150000003839 salts Chemical class 0.000 claims description 25
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 21
- 235000011090 malic acid Nutrition 0.000 claims description 19
- 229940116298 l- malic acid Drugs 0.000 claims description 15
- -1 L-arginine L-malate anhydride Chemical class 0.000 claims description 5
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 230000001376 precipitating effect Effects 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 19
- 239000007864 aqueous solution Substances 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229940099690 malic acid Drugs 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010020575 Hyperammonaemia Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 150000008535 L-arginines Chemical class 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 238000004455 differential thermal analysis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- DFQICHCWIIJABH-UHFFFAOYSA-N naphthalene-2,7-diol Chemical compound C1=CC(O)=CC2=CC(O)=CC=C21 DFQICHCWIIJABH-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28488086A JPS62142150A (ja) | 1986-11-28 | 1986-11-28 | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28488086A JPS62142150A (ja) | 1986-11-28 | 1986-11-28 | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4237879A Division JPS55136254A (en) | 1978-11-20 | 1979-04-06 | Basic l-amino acid l-malic acid salt crystal and its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62142150A true JPS62142150A (ja) | 1987-06-25 |
| JPS6332781B2 JPS6332781B2 (enrdf_load_stackoverflow) | 1988-07-01 |
Family
ID=17684231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP28488086A Granted JPS62142150A (ja) | 1986-11-28 | 1986-11-28 | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62142150A (enrdf_load_stackoverflow) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS536204A (en) * | 1976-07-08 | 1978-01-20 | Kubota Ltd | Scum removing apparatus |
-
1986
- 1986-11-28 JP JP28488086A patent/JPS62142150A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS536204A (en) * | 1976-07-08 | 1978-01-20 | Kubota Ltd | Scum removing apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6332781B2 (enrdf_load_stackoverflow) | 1988-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4420432A (en) | Crystalline salt of basic L-amino acid with L-malic acid and process for the preparation thereof | |
| US20040062844A1 (en) | Salts of L-amino acids having improved taste and their preparation | |
| JP3113026B2 (ja) | 濃厚液組成物 | |
| TWI279230B (en) | Pregabalin composition | |
| CA2255665C (en) | Creatine pyruvates and method for their production | |
| CN103690521B (zh) | 一种葡萄糖酸钙锌口服溶液 | |
| JP2008513519A (ja) | 安定した凍結乾燥されたアントラサイクリングリコシド | |
| CN113956250A (zh) | 盐酸小檗碱药物共晶及其制备方法和用途 | |
| US2427692A (en) | Therapeutic metal cevitamate compositions | |
| CN117243936B (zh) | 一种复方钙制剂组合物及其制备方法 | |
| JPS63156719A (ja) | シロツプ剤 | |
| JPS62142150A (ja) | 中性ｌ−アルギニン・ｌ−リンゴ酸塩結晶およびその製法 | |
| JPH0217559B2 (enrdf_load_stackoverflow) | ||
| US7109373B2 (en) | Creatine salts and method of making same | |
| JPH0543590A (ja) | 結晶ラクチユロース三水和物とその製造法 | |
| JPS6328419B2 (enrdf_load_stackoverflow) | ||
| JP4678079B2 (ja) | リボフラビン配合液剤組成物 | |
| US20070093677A1 (en) | Creatine salts and method of making same | |
| CN111423480B (zh) | 一种莱鲍迪苷e的晶型x、其制备方法和用途 | |
| JP4206506B2 (ja) | ビタミンｂ１類を配合した液剤 | |
| JPS5865214A (ja) | Ｎ−アシル−ｌ−アスパルチルタウリンを含有する医薬 | |
| JP4013267B2 (ja) | 内服液剤 | |
| JP4193218B2 (ja) | ビオチンの溶解方法及びビオチン含有内服液剤 | |
| JP2002363173A (ja) | アセスルファム塩、その製造及び使用法 | |
| EP1264821A1 (en) | Novel crystal of stilbene derivative and process for producing the same |